Company / Depreciation & Amortization
Insulet Corporation Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$90.4M
FY2025
5-year range
$57.4M / $90.4M
FY2021-FY2025
Trend
+11.9%
vs FY2024
Sector context
#64 of 135
Health Care
What the data says
At $90M, Insulet Corporation's depreciation & amortization ranks #72 of 135 in the Health Care sector. Depreciation & Amortization has increased for 9 consecutive years, from $14M in FY2016 to $90M in FY2025.
Based on SEC 10-K filings.
$90M in FY2025 with a 5-year CAGR of +10.3%.
Increased from $73M to $90M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#72 of 135 in Health CareTop 53% of 135This company $90.4M Sector average $334.5M
▼
-73.0% below sector average
Key checks
Key Insights
- Insulet Corporation's depreciation & amortization has grown for 9 consecutive years.
- 5-year CAGR of +10.3%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 11.9% year-over-year.
- Ranks #64 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $90.4M | +11.9% |
| FY2024 | $80.8M | +11.0% |
| FY2023 | $72.8M | +15.2% |
| FY2022 | $63.2M | +10.1% |
| FY2021 | $57.4M | +3.6% |
| FY2020 | $55.4M | +98.6% |
| FY2019 | $27.9M | +78.8% |
| FY2018 | $15.6M | +12.2% |
| FY2017 | $13.9M | +0.5% |
| FY2016 | $13.8M | -12.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026